Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Schedule of derivative liabilities measured at fair value
    Significant Unobservable Inputs
(Level 3)
 
Balance of derivative liabilities as of January 1, 2019   $ -  
Initial fair value of derivative liabilities attributable to warrants issuance with fund raise     4,217,241  
Gain from change in the fair value of derivative liabilities     (2,817,241 )
Warrants were redeemed and cancelled     (1,400,000 )
Balance of derivative liabilities as of December 31, 2019   $ -  
Schedule of cash balances by geographic area
Country:   December 31,
2019
    December 31,
2018
 
United States   $ 371,929       48.6 %   $ 1,035,802       46.0 %
China     392,962       51.4 %     1,216,485       54.0 %
Total cash   $ 764,891       100.0 %   $ 2,252,287       100.0 %
Schedule of disaggregation of revenue

For the Year Ended December 31, 2019   Medical Related Consulting Services Segment     Development services and sales of Developed Products Segment     Total  
Medical related consulting services - related parties   $ 355,544     $ -     $ 355,544  
Development services and sales of developed products     -       35,084       35,084  
Total revenues   $ 355,544     $ 35,084     $ 390,628  

 

For the Year Ended December 31, 2018   Medical Related Consulting Services Segment     Development services and sales of Developed Products Segment     Total  
Medical related consulting services - related parties   $ 269,287     $ -     $ 269,287  
Development services and sales of developed products     -       171,516       171,516  
Total revenues   $ 269,287     $ 171,516     $ 440,803  
Schedule of the effect of including these potential shares was antidilutive
  Years Ended December 31,  
    2019     2018  
Stock options     5,260,000       2,840,000  
Warrants     2,293,179       578,891  
Potentially dilutive securities     7,553,179       3,418,891